Vivos Therapeutics, Inc. is a medical technology company focused on developing and commercializing diagnostic and treatment methods that promote sleep wellness and health for patients suffering from breathing and sleep issues such as obstructive sleep apnea (OSA) and snoring in adults. The Company's Complete Airway Repositioning and/or Expansion (CARE) devices are the oral appliances cleared by the United States Food and Drug Administration (FDA) for adult patients diagnosed with all severity levels of OSA (including severe OSA) and moderate-to-severe OSA in children ages 6 to 17 within the FDA cleared usage for such devices. The Company's products and services include Vivos CARE oral appliance therapy, Vivos oral appliances and therapies outside of CARE system, Vivos AireO2, Adjunctive Treatment, Treatment Navigator, Vivos Billing Intelligence Service (BIS) and Vivos Airway Intelligence Service, and others. The Company has sleep testing centers and associated medical sleep practice.
企業コードVVOS
会社名Vivos Therapeutics Inc
上場日Dec 11, 2020
最高経営責任者「CEO」Huntsman (R. Kirk)
従業員数109
証券種類Ordinary Share
決算期末Dec 11
本社所在地7921 Southpark Plaza,
都市LITTLETON
証券取引所NASDAQ OMX - NASDAQ BASIC
国United States of America
郵便番号80120
電話番号18669084867
ウェブサイトhttps://vivos.com/
企業コードVVOS
上場日Dec 11, 2020
最高経営責任者「CEO」Huntsman (R. Kirk)
過去5年間の配当金総支払額は
0.00
米ドルである。

データなし